Scarica l'app Stockscreener
1.44
5.11%
0.07
Precedente Chiudi:
$1.37
Aprire:
$1.38
Volume 24 ore:
109.54K
Relative Volume:
0.44
Capitalizzazione di mercato:
$23.14M
Reddito:
-
Utile/perdita netta:
$-8.29M
Rapporto P/E:
-2.0571
EPS:
-0.7
Flusso di cassa netto:
$-6.47M
1 W Prestazione:
-4.00%
1M Prestazione:
-15.29%
6M Prestazione:
-4.00%
1 anno Prestazione:
-21.74%
Intervallo 1D:
$1.37
$1.45
Intervallo di 1 settimana:
$1.3401
$1.57
Portata 52W:
$0.94
$2.07
NanoViricides Inc Stock (NNVC) Company Profile
Nome
NanoViricides Inc
Settore
Industria
Telefono
203-937-6137
Indirizzo
1 Controls Drive, Shelton, CT
Confronta NNVC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NNVC
NanoViricides Inc
|
1.44 | 24.59M | 0 | -8.29M | -6.47M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
NanoViricides Inc Stock (NNVC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2015-02-11 | Iniziato | Midtown Partners | Strong Buy |
NanoViricides Inc Borsa (NNVC) Ultime notizie
Heatmap analysis for NanoViricides Inc. and competitorsJuly 2025 Outlook & Scalable Portfolio Growth Methods - Newser
Risk adjusted return profile for NanoViricides Inc. analyzedEarnings Growth Report & Verified Technical Signals - Newser
Will NanoViricides Inc. rebound enough to break evenRecession Risk & Long-Term Capital Growth Strategies - Newser
Technical Bounce Expected in NanoViricides Inc. Next Week2025 Major Catalysts & Reliable Trade Execution Plans - mustnews.co.kr
Historical volatility pattern of NanoViricides Inc. visualized2025 Key Highlights & Community Verified Trade Alerts - Newser
Analyzing net buyer seller activity in NanoViricides Inc.Portfolio Profit Report & Safe Capital Growth Tips - Newser
Market reaction to NanoViricides Inc.’s recent newsTrade Volume Report & Real-Time Stock Price Movement Reports - Newser
NanoViricides Inc. stock retracement – recovery analysisJuly 2025 Market Mood & Fast Exit and Entry Strategy Plans - Newser
Signal strength of NanoViricides Inc. stock in tech scannersMarket Activity Report & Entry Point Confirmation Signals - Newser
NanoViricides Inc. recovery potential after sell offJuly 2025 Opening Moves & Community Verified Watchlist Alerts - Newser
Why NanoViricides Inc. stock attracts strong analyst attentionWeekly Stock Recap & Real-Time Volume Analysis - Newser
Real time social sentiment graph for NanoViricides Inc.July 2025 Retail & Consistent Profit Trade Alerts - Newser
Small Cap Stocks: 374Water, Canagold Resources, Ocean Power, Giyani Metals, NanoViricides, Viking Therapeutics, HIVE Digital Technologies, American Resources Corp, Ocean Power Technologies, 374Water Inc, Canagold Resources Ltd. - AInvest
NanoViricides' NV-387 May Reduce Cancer Resurgence Risk Linked to Viral Infections - AInvest
Using Python tools to backtest NanoViricides Inc. strategiesTrade Entry Summary & Weekly Breakout Stock Alerts - Newser
Published on: 2025-08-19 13:51:24 - Newser
Nanoviricides, Inc. shares rise 1.31% premarket after announcing NV-387 antiviral drug's potential for treating multiple viral infections. - AInvest
Sentiment analysis tools applied to NanoViricides Inc.July 2025 Selloffs & Risk Managed Investment Signals - Newser
Multi Factor Analysis Ranks NanoViricides Inc. as Strong BuyPortfolio Gains Report & Long-Term Safe Investment Plans - theviewers.co.kr
What MACD and RSI say about NanoViricides Inc.2025 Geopolitical Influence & High Accuracy Investment Signals - Newser
What makes NanoViricides Inc. stock price move sharplyRisk Management & Long Hold Capital Preservation Tips - Newser
NanoViricides says antiviral NV-387 may reduce cancer resurgence risk tied to viral infections - Proactive financial news
A Drug that Could Reduce Metastatic Cancer Resurgence due to Its Anti-Inflammatory Effects in Viral Infections is in Clinical Trials - Lelezard
Breakthrough Anti-viral Drug NV-387 Could Stop Dormant Cancer Cells From Reawakening After Viral Infections - Stock Titan
Is NanoViricides Inc. still worth holding after the dipJuly 2025 Reactions & Long-Term Growth Plans - Newser
Is NanoViricides Inc. Stock a Smart Buy in 2025 Investment Analysis InsideTrade Entry Report & Long-Term Investment Growth Plans - Newser
Intraday pattern recognizer results for NanoViricides Inc.Weekly Trend Report & Low Drawdown Momentum Ideas - Newser
NanoViricides Inc. stock momentum explainedEntry Point & High Return Stock Watch Alerts - Newser
How to integrate NanoViricides Inc. into portfolio analysis toolsQuarterly Portfolio Review & Free High Return Stock Watch Alerts - Newser
Will NanoViricides Inc. outperform the marketVolume Spike & Technical Confirmation Trade Alerts - Newser
Automated trading signals detected on NanoViricides Inc.2025 Volume Leaders & Expert Curated Trade Ideas - Newser
Can NanoViricides Inc. maintain its current growth rateQuarterly Portfolio Review & Daily Profit Maximizing Tips - thegnnews.com
Real time breakdown of NanoViricides Inc. stock performanceRate Cut & Safe Capital Growth Stock Tips - Newser
XTX Topco Ltd Takes Position in NanoViricides, Inc. (NYSE:NNVC) - Defense World
NanoViricides Inc Azioni (NNVC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.94%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):